PRS Global Open • 2019 in the facial fat graft applied in the mandibular region. The changes in the fat graft area were comparable to the changes in other tissues in the facial region during pregnancy in terms of volume gain.
As mentioned earlier, Taupin et al 1 reported that young patients with unilateral fat grafts are at risk of undesirable volume changes of a fat graft after weight gain. Growth in length and width cannot always be predicted for future life. Nevertheless, knowledge about weight gain and pregnancy in relation to fat grafting would be helpful to prevent undesirable asymmetries in young patients. Based on our case, pregnancy does not seem to be a major factor.
The average gain in body weight during pregnancy is 10.8-12 kg, with an estimated increase of 6%-7% of body fat. 3 The percentage of fat tissue increases slowly until the 24th week of gestation and remains stable after that until the time of delivery. 2 In contrast to fat percentage gain, extracellular fluid increases from the 24th week until the 40th week of gestation, resulting in a weight gain of approximately 1.5 kg. 2 In our case, the extra volume gain around the cheeks on both sides was observed in the second and third trimesters. It is unclear whether the fat or the extracellular fluid caused this bilateral volume gain in the face.
In our case, subcutaneous adipose tissue from the inner knee was used for fat grafting. In women, femoral subcutaneous adipose tissue is comparable to abdominal subcutaneous adipose tissue with regard to fat local thickness and number of adipocytes. 4, 5 Although no literature is available about changes in subcutaneous femoral adipose tissue during pregnancy, if any, it has been shown that the increase of abdominal fat during pregnancy is a result of an accumulation of visceral adipose tissue and not caused by accumulation of subcutaneous abdominal adipose tissue during pregnancy. 6, 7 This conclusion is in line with our finding that the subcutaneous fat graft did not increase in volume during pregnancy.
An animal study by Mok et al 8 stated that high estrogen levels during fat graft transplantation did not lead to higher volume retention in mice. High estrogen is related to a lower acute inflammation response because it inhibits neutrophils and M1 macrophages. However, in their study, some mice had low and some high estrogen levels at the time of transplantation and were followed up at 4 and 12 weeks. In our case, high estrogen levels occurred 3 weeks after the transplantation due to pregnancy onset at that time. We presume that the acute inflammation response was not lower due to this 3-week gap between injection of the fat graft and the conception.
The fat graft did not increase disproportionally during pregnancy, but this observation can be criticized. First, it is possible that the fat graft increased in volume due to pregnancy, but at the same time, it decreased due to physiologic fat graft remodeling. It is known that during the first months after transplantation, volume of a fat graft will decrease. [9] [10] [11] Second, a low amount of 7 ml of fat was injected and changes Our case showed that a unilateral small facial fat graft did not undergo noticeable volumetric changes during pregnancy. This presumption is based on a single case, however. To improve scientific evidence, larger studies are needed to objectify possible volume changes of facial fat grafts during pregnancy.
